MedPath

CYPROHEPTADINE HYDROCHLORIDE

Cyproheptadine Hydrochloride Tablets, USP

Approved
Approval ID

ccd7d3b2-b0c1-4f66-8d06-d21f5cfa8c1e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 4, 2022

Manufacturers
FDA

Zydus Lifesciences Limited

DUNS: 918596198

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CYPROHEPTADINE HYDROCHLORIDE

PRODUCT DETAILS

NDC Product Code70771-1076
Application NumberANDA208938
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateAugust 4, 2022
Generic NameCYPROHEPTADINE HYDROCHLORIDE

INGREDIENTS (5)

CYPROHEPTADINE HYDROCHLORIDEActive
Quantity: 4 mg in 1 1
Code: NJ82J0F8QC
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
CYPROHEPTADINE HYDROCHLORIDE - FDA Approval | MedPath